Results

Latest quarterly results

Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.

878 companies in Healthcare reported in the last 30 days · showing 351–400 · updated Wed, Nov 18, 2026

CompanySectorReportedQuarter RevenueRev. YoYNet incomeNI YoYEPSEPS YoY Op. marginMargin chg.Market cap
NXTCNextCure, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$7.0M n/m −$1.29 n/m — — $31M
ABVCABVC BioPharma, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m $1.0M n/m $0.04 n/m — — $25M
QTIQT Imaging Holdings, Inc. Healthcare Nov 10 Sep '26 $7.0M +75.0% $0.0M n/m −$0.02 n/m -33.4% +6.1 pp $25M
MGXMetagenomi Therapeutics, Inc. Healthcare Nov 10 Sep '26 $2.0M −77.8% −$21.0M n/m −$0.56 n/m — — $24M
LITSLite Strategy, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m $16.0M n/m $0.48 n/m — — $24M
ATOSAtossa Therapeutics, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$6.0M n/m −$0.56 n/m — — $19M
CNTXContext Therapeutics Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$8.0M n/m −$0.08 n/m — — $16M
SNWVSANUWAVE Health, Inc. Healthcare Nov 10 Sep '26 $9.0M −18.2% −$1.0M −110.0% −$0.16 −114.2% -12.5% −25.3 pp $15M
PASGPassage Bio, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$5.0M n/m −$1.47 n/m — — $14M
BNGOBionano Genomics, Inc. Healthcare Nov 10 Sep '26 $8.0M +14.3% −$6.0M n/m −$0.54 n/m -79.0% +36.9 pp $13M
CLRBCellectar Biosciences, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$8.0M n/m −$0.46 n/m — — $9M
INBSIntelligent Bio Solutions Inc. Healthcare Nov 10 Sep '26 $1.0M 0.0% −$3.0M n/m −$0.86 n/m -192.8% +70.9 pp $5M
SNOASonoma Pharmaceuticals, Inc. Healthcare Nov 10 Sep '26 $7.0M +16.7% $0.0M n/m −$0.01 n/m 4.0% +10.1 pp $4M
CALCCalciMedica, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$2.0M n/m −$0.24 n/m — — $4M
DRMADermata Therapeutics, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$3.0M n/m −$0.55 n/m — — $3M
CODXCo-Diagnostics, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$6.0M n/m −$1.01 n/m — — $1M
AMIXAutonomix Medical, Inc. Healthcare Nov 10 Sep '26 $0.0M n/m −$3.0M n/m −$2.51 n/m — — $586,766
ROIVRoivant Sciences Ltd. Healthcare Nov 9 Sep '26 $35.1M +1,650% — n/m −$0.27 n/m -763.2% — $28.0B
TECHBio-Techne Corp Healthcare Nov 9 Sep '26 $300M +4.5% $28.0M −26.3% $0.18 −25.0% 12.2% −4.4 pp $11.4B
TGTXTG Therapeutics, Inc. Healthcare Nov 9 Sep '26 $260M +60.5% $55.0M −85.9% $0.35 −85.6% 33.0% +14.9 pp $9.5B
PRAXPraxis Precision Medicines, Inc. Healthcare Nov 9 Sep '26 $0.0M n/m −$94.0M n/m −$3.23 n/m — — $8.5B
IMVTImmunovant, Inc. Healthcare Nov 9 Sep '26 $0.0M n/m −$97.0M n/m −$0.47 n/m — — $6.9B
IBRXImmunityBio, Inc. Healthcare Nov 9 Sep '26 $49.0M +53.1% −$185M n/m −$0.18 n/m -159.7% +13.8 pp $6.7B
ORKAOruka Therapeutics, Inc. Healthcare Nov 9 Sep '26 $0.0M n/m −$50.0M n/m −$0.63 n/m — — $6.5B
IONSIonis Pharmaceuticals, Inc. Healthcare Nov 9 Sep '26 $243M +54.8% −$110M n/m −$0.66 n/m -53.9% +48.4 pp $4.5B
DFTXDefinium Therapeutics, Inc. Healthcare Nov 9 Sep '26 $0.0M n/m −$51.0M n/m −$0.37 n/m — — $4.0B
HIMSHims & Hers Health, Inc. Healthcare Nov 9 Sep '26 $890M +48.6% −$33.0M −306.2% −$0.14 −333.3% -7.4% −9.4 pp $4.0B
XENEXenon Pharmaceuticals Inc. Healthcare Nov 9 Sep '26 $0.0M n/m −$110M n/m −$1.11 n/m — — $3.8B
TNGXTango Therapeutics, Inc. Healthcare Nov 9 Sep '26 $0.0M −100.0% −$68.0M −525.0% −$0.39 −378.6% — — $3.7B
ABCLAbCellera Biologics Inc. Healthcare Nov 9 Sep '26 $11.0M +22.2% −$41.0M n/m −$0.13 n/m -501.1% +350.7 pp $3.6B
SGRYSurgery Partners, Inc. Healthcare Nov 9 Sep '26 $815M −0.9% −$21.0M n/m −$0.16 n/m 10.5% −2.4 pp $3.5B
MBXMBX Biosciences, Inc. Healthcare Nov 9 Sep '26 $0.0M n/m −$62.0M n/m −$1.29 n/m — — $2.6B
IMNMImmunome, Inc. Healthcare Nov 9 Sep '26 $0.0M n/m −$86.0M n/m −$0.76 n/m — — $2.0B
TRVITrevi Therapeutics, Inc. Healthcare Nov 9 Sep '26 $0.0M n/m −$21.0M n/m −$0.13 n/m — — $1.9B
SEPNSepterna, Inc. Healthcare Nov 9 Sep '26 $19.0M −9.5% −$27.0M −437.5% −$0.57 −416.7% -144.2% −156.4 pp $1.9B
ZYMEZymeworks Inc. Healthcare Nov 9 Sep '26 $256M +814.3% $174M n/m $2.28 n/m 69.3% +149.3 pp $1.8B
MAZEMaze Therapeutics, Inc. Healthcare Nov 9 Sep '26 $0.0M n/m −$48.0M n/m −$0.79 n/m — — $1.8B
WGSGeneDx Holdings Corp. Healthcare Nov 9 Sep '26 $123M +5.1% −$12.0M n/m −$0.41 n/m -8.5% −5.7 pp $1.4B
OCULOcular Therapeutix, Inc. Healthcare Nov 9 Sep '26 $13.0M −13.3% −$95.0M n/m −$0.42 n/m -760.1% −287.8 pp $1.3B
HROWHarrow, Inc. Healthcare Nov 9 Sep '26 $99.0M +37.5% $10.0M +900.0% $0.25 +733.3% 11.6% −9.0 pp $1.1B
SVRASavara, Inc. Healthcare Nov 9 Sep '26 $0.0M n/m −$43.0M n/m −$0.17 n/m — — $988M
MLABMesa Laboratories, Inc. Healthcare Nov 9 Sep '26 $62.0M +1.6% $4.0M +100.0% $0.75 +66.7% 13.5% +5.7 pp $757M
AURAAura Biosciences, Inc. Healthcare Nov 9 Sep '26 $0.0M n/m −$32.0M n/m −$0.29 n/m — — $744M
ATTOAttovia Therapeutics, Inc. Healthcare Nov 9 Sep '26pending $0.5M† — — — — — — — $679M
DCTHDelcath Systems, Inc. Healthcare Nov 9 Sep '26 $35.0M +66.7% $7.0M +600.0% $0.17 +750.0% 20.3% +22.2 pp $674M
BCAXBicara Therapeutics Inc. Healthcare Nov 9 Sep '26 $0.0M n/m −$71.0M n/m −$1.04 n/m — — $637M
GMRSGMR Solutions Inc. Healthcare Nov 9 Sep '26 $1.60B — $136M — $0.56 — 16.4% — $605M
ANNXAnnexon, Inc. Healthcare Nov 9 Sep '26 $0.0M n/m −$51.0M n/m −$0.25 n/m — — $569M
SENSSenseonics Holdings, Inc. Healthcare Nov 9 Sep '26 $20.0M +150.0% −$33.0M n/m −$0.50 n/m -162.8% +79.3 pp $557M
AVBPArriVent BioPharma, Inc. Healthcare Nov 9 Sep '26 $5.0M n/m −$40.0M n/m −$0.81 n/m 0.0% — $553M
  • Report dates come from the earnings calendar (dates loaded Oct 4 to Dec 9); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
  • YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
  • pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.